Clinical Trial

EptinezuMaB in ReAl-world evidenCE: Multicenter, Real Life, Cohort Study in Migraine.

Study acronym: EMBRACE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 1, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The object of this study is to assess the effectiveness, safety, and tolerability of eptinezumab in a real life migraine population.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-10-04; most recent amendment 2025-04-29.
Status change: Not Yet Recruiting → Recruiting 2024-01-10
Trial Details
NCT Number NCT05570149
Lead Sponsor IRCCS San Raffaele Roma
Conditions Migraine Disorders
Enrollment 500 participants
Start Date 2023-01-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-01